Results

Total Results: 423 records

Showing results for "aspirin".

61. Archived: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
    March 15, 2007 - Benefits of aspirin and NSAID use: There is fair to good evidence that aspirin and NSAIDs, taken in … Harms of aspirin and NSAID use: There is good evidence that aspirin increases the incidence of gastrointestinal … (more than fourteen 325-mg aspirin tablets per week). … A prospective study of aspirin use and the risk for colorectal adenoma. … Major study debunks aspirin, vitamin E for cancer prevention. 2005.

62. Draft Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality-preventive-medication1
    June 20, 2019 - in progress Draft Research Plan Aspirin Use to Prevent Preeclampsia and Related Morbidity and … Does the effectiveness of aspirin for reducing adverse health outcomes vary by subpopulations defined … Does aspirin prevent preeclampsia in pregnant persons at increased risk for preeclampsia? … Does the effectiveness of aspirin for reducing preeclampsia vary by subpopulations defined by personal … What are the harms of aspirin use to prevent preeclampsia during pregnancy?

63. Final Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
    May 14, 2020 - in progress Final Research Plan Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … Key Questions to Be Systematically Reviewed Does regular aspirin use in patients without known … Does the effect vary by dose or duration of aspirin use? … Does the effect vary by dose or duration of aspirin use? … Current recommendations for aspirin use involve CVD risk estimation using the Pooled Cohort Equations

64. Final Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    May 14, 2020 - to WhatsApp Share to Email Print Final Research Plan Aspirin … Does the effect vary by dose or duration of aspirin use? … Does the effect vary by dose or duration of aspirin use? … Current recommendations for aspirin use involve CVD risk estimation using the Pooled Cohort Equations … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes

65. Let's Talk About It: Starting Aspirin to Prevent Heart Disease and Stroke Discussion Guide for Healthcare Professionals and Patients | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/lets-talk-about-it-discussion-guides/lets-talk-about-it-starting-aspirin-prevent-heart-disease-and-stroke-discussion-guide-healthcare-professionals-and-patients
    April 19, 2025 - Let's Talk About It: Starting Aspirin to Prevent Heart Disease and Stroke Discussion Guide for Healthcare … Print Download English PDF Download Spanish PDF   Let’s Talk About It: Starting Aspirin … Disease and Stroke (PDF File, 187 KB;  PDF Help ) To support implementation of the recommendation on Aspirin … It outlines basic information about the benefits and harms of aspirin use to prevent a first heart attack … questions for patients ages 40 to 59 and 60 and older to ask their healthcare professionals about starting aspirin

66. Final Recommendation Statement: Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-aspirin-use-primary-prevention-cardiovascular-disease-and-colorectal-cancer
    March 09, 2024 - Final Recommendation Statement: Aspirin Use for the Primary Prevention of Cardiovascular Disease and … Preventive Services Task Force released today a final recommendation statement on aspirin use for the … Evidence shows that low-dose aspirin use is most beneficial for adults ages 50 to 59 years. … Adults ages 60 to 69 years should decide with their primary care clinician if aspirin use for primary … based, please go to  http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer

67. Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication
    January 30, 2020 - in progress Draft Research Plan Aspirin Use to Prevent Cardiovascular Disease and Colorectal … Does the effect vary by dose or duration of aspirin use? … Does the effect vary by dose or duration of aspirin use? … Current recommendations for aspirin use involve CVD risk estimation using the Pooled Cohort Equations … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes

68. Draft Research Plan: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
    January 30, 2020 - in progress Draft Research Plan Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication … Does the effect vary by dose or duration of aspirin use? … Does the effect vary by dose or duration of aspirin use? … Current recommendations for aspirin use involve CVD risk estimation using the Pooled Cohort Equations … What is the effect of aspirin discontinuation on CVD, CRC, all-cause mortality, and bleeding outcomes

69. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
    March 15, 2009 - Analytical framework: aspirin to prevent cardiovascular events Figure 2. … Does aspirin increase gastrointestinal bleeding or hemorrhagic strokes? … Men have an increased risk for hemorrhagic strokes with aspirin use. … Aspirin use increases the risk for serious bleeding events. … Randomised trial of prophylactic daily aspirin in British male doctors.

70. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
    March 15, 2009 - Analytical framework: aspirin to prevent cardiovascular events Figure 2. … Does aspirin increase gastrointestinal bleeding or hemorrhagic strokes? … Men have an increased risk for hemorrhagic strokes with aspirin use. … Aspirin use increases the risk for serious bleeding events. … Randomised trial of prophylactic daily aspirin in British male doctors.

71. U.S. Preventive Services Task Force Issues Final Research Plan for Aspirin Use for the Primary Prevention of Cancer and Aspirin Use for the Primary Prevention of Cardiovascular Events | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-research-plan-aspirin-use-primary-prevention-cancer-and-aspirin-use-primary-prevention
    October 18, 2013 - Preventive Services Task Force Issues Final Research Plan for Aspirin Use for the Primary Prevention … of Cancer and Aspirin Use for the Primary Prevention of Cardiovascular Events Share to … The first is on aspirin use for the primary prevention of cancer. … In response to public comments asking for a more integrated approach to recommendations on aspirin use … , the Task Force broadened the scope of the final Research Plan to include aspirin use to prevent all

72. Task Force Issues Draft Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/aspirin-cvd-prevention-final-rec-bulletin.pdf
    November 08, 2021 - Task Force Issues Draft Recommendation Statement on Aspirin Use to Prevent Cardiovascular Disease … www.uspreventiveservicestaskforce.org 1 Task Force Issues Draft Recommendation Statement on Aspirin … Preventive Services Task Force (Task Force) today posted a draft recommendation statement on aspirin … People age 60 or older should not start taking aspirin for heart disease and stroke prevention. … While daily aspirin use has been shown to lower the chance of having a first heart attack or stroke,

73. Task Force Finalizes Recommendations on Starting Aspirin Use to Prevent a First Heart Attack or Stroke (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/aspirin-cvd-prevention-final-rec-bulletin_0.pdf
    April 26, 2022 - Task Force Finalizes Recommendations on Starting Aspirin Use to Prevent a First Heart Attack or Stroke … Stroke People 40 to 59 should decide with their healthcare professional whether to start taking aspirin … Preventive Services Task Force (Task Force) today published a final recommendation statement on aspirin … People age 60 or older should not start taking aspirin to prevent a first heart attack or stroke. … right for them because daily aspirin use does come with possible serious harms.”

74. JAMA (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ymZSPeLcwZ9rxTC-7zdWbp
    July 11, 2022 - low-dose aspirin. … Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. … Low-dose aspirin to prevent preeclampsia in women at high risk. … aspirin study in pregnancy. … ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy.

75. Let's Talk About It: Starting Aspirin to Prevent Heart Disease and Stroke Discussion Guide for Healthcare Professionals and Patients | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/lets-talk-about-it-starting-aspirin-prevent-heart-disease-and-stroke-discussion-guide-healthcare-professionals-and-patients
    August 20, 2023 - Let's Talk About It: Starting Aspirin to Prevent Heart Disease and Stroke Discussion Guide for Healthcare … Download English PDF Download Spanish PDF   Let’s Talk About It: Starting Aspirin … Disease and Stroke (PDF File, 187 KB;  PDF Help ) To support implementation of the recommendation on Aspirin … It outlines basic information about the benefits and harms of aspirin use to prevent a first heart attack … questions for patients ages 40 to 59 and 60 and older to ask their healthcare professionals about starting aspirin

76. Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
    September 26, 2019 - to WhatsApp Share to Email Print Final Research Plan Aspirin … Does the effectiveness of aspirin for reducing adverse health outcomes vary by subpopulations defined … Does aspirin prevent preeclampsia in pregnant persons at increased risk for preeclampsia? … Does the effectiveness of aspirin for reducing preeclampsia vary by subpopulations defined by personal … What are the harms of aspirin use to prevent preeclampsia during pregnancy?

77. Final Recommendation Statement: Aspirin to Prevent Cardiovascular Disease | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/final-recommendation-statement-aspirin-prevent-cardiovascular-disease
    April 26, 2022 - Final Recommendation Statement: Aspirin to Prevent Cardiovascular Disease Share to Facebook … Preventive Services Task Force released today a final recommendation statement on aspirin use to prevent … 40 to 59 who are at higher risk for CVD should decide with their clinician whether to start taking aspirin … ; people 60 or older should not start taking aspirin to prevent a first heart attack or stroke.

78. Aspirin Use to Prevent CVD Draft Recommendation Statement | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/aspirin-use-prevent-cvd-draft-recommendation-statement
    November 08, 2021 - Current Terms and Conditions Page 1 Page 2 Contact Information Complete The U.S. Preventive Services Task Force (USPSTF) welcomes yo…

79. Aspirin to Prevent CVD Draft Modeling Report | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/aspirin-use-cvd-prevention-draft-modeling-report
    November 08, 2021 - Current Terms and Conditions Page 1 Page 2 Contact Information Complete The U.S. Preventive Services Task Force (USPSTF) welcomes yo…

80. Public Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Report: Aspirin Use to Prevent Cardiovascular Disease | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-statement-draft-evidence-review-and-draft-modeling-report-aspirin-use-prevent-cardiovascular
    November 08, 2021 - Public Comment on Draft Recommendation Statement, Draft Evidence Review, and Draft Modeling Report: Aspirin … seeks comments on a draft recommendation statement, draft evidence review, and draft modeling report on aspirin … People 40 to 59 should decide with their clinician whether to start taking aspirin; people 60 and older … should not start taking aspirin.